top of page
Digital Health London’s Accelerator programme selects Aide
Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions
QUANTUNG PHARMA
University of Oxford and PrecisionLife reach data agreement
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis
QUANTUNG PHARMA
Genfit and Ipsen announce elafibranor results
ELATIVE, a randomised PBC trial involving 161 patients, has successfully met its primary endpoint
QUANTUNG PHARMA
Teva reveals critical Ajovy data
Therapy has been developed to reduce the frequency, duration and severity of migraine attacks
QUANTUNG PHARMA
Momentum for Poolbeg and CytoReason’s AI collaboration
Partnership establishes several influenza therapy targets using artificial intelligence
QUANTUNG PHARMA
Novartis reveals five-year efficacy data for Kesimpta
Patients treated with Kesimpta experienced considerable decreases in relapse rates
QUANTUNG PHARMA
GeneCode receives record Parkinson’s funding
European Innovation Council Accelerator finances treatment development drive for condition
QUANTUNG PHARMA
Positive efficacy data for Sensorian’s candidate I QUANTUNG Pharma
SENS-401 has been developed for hearing preservation among adult patients following cochlear implantation
QUANTUNG PHARMA
Biotech firms target weight-loss drugs without Wegovy's side-effects
Biotech firms target weight-loss drugs without Wegovy's side-effects, QUNATUNG Pharma
QUANTUNG PHARMA
Incyte’s Opzelura gets MHRA authorisation
Incyte Biosciences has announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation for
QUANTUNG PHARMA
Novavax COVID-19 vaccine produces immunity
Researchers leading the University of Oxford’s Com-COV3 study have delivered results from a study researching the immune response and side-e
QUANTUNG PHARMA
em que pé está a canábis medicinal em Portugal?
Conheça os contornos deste novo método medicinal, o que é legal em Portugal e as diferentes opiniões quanto à sua utilização, neste espaço d
QUANTUNG PHARMA
Canábis em Portugal
A canábis em Portugal foi descriminalizada em 2001, quando a posse de todas as drogas ilícitas foi descriminalizada no país, sendo as sançõe
QUANTUNG PHARMA
Canábis para fins medicinais
A Lei n.º 33/2018, de 18 de julho, estabeleceu o quadro legal para a utilização de medicamentos, preparações e substâncias à base da planta
QUANTUNG PHARMA
Global cannabis testing market to grow 13.4% through 2025
The latest news on health and medicine, covid, vaccines, global health, mental health, Obamacare, health insurance, Medicare, Medicaid, opio
QUANTUNG PHARMA
New discovery shows cannabis reduces blood pressure for older people
For doctors working in cannabis medical research, clinical practice, medical education and healthcare policy: news, analyses, editorials, co
QUANTUNG PHARMA
Uruguai concretiza exportação história de cannabis medicinal
For doctors working in cannabis medical research, clinical practice, medical education and healthcare policy: news, analyses, editorials, co
QUANTUNG PHARMA
2021, canábis medicinal finalmente nas farmácias?
Medical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, p
QUANTUNG PHARMA
Primeira substância à base da planta da cannabis para fins medicinais aprovada em Portugal
Primeira substância à base da planta da cannabis para fins medicinais aprovada em Portugal
QUANTUNG PHARMA
Maior plantação europeia de Cannabis medicinal fica em Portugal
Maior plantação europeia de Cannabis medicinal fica em Portugal
QUANTUNG PHARMA
bottom of page